We are live on ! Find out more
CAPTRUST Financial Advisors

CAPTRUST Financial Advisors Portfolio holdings

AUM $57.3B
1-Year Est. Return 18.32%
This Fund
S&P 500
This Quarter Est. Return
-2.65%
1 Year Est. Return
+18.32%
3 Year Est. Return
+60%
5 Year Est. Return
+73.18%
10 Year Est. Return
+239.88%
AUM
$15.4B
AUM Growth
+$868M
Cap. Flow
+$1.46B
Cap. Flow %
9.44%
Top 10 Hldgs %
23.12%
Holding
5,652
New
615
Increased
2,530
Reduced
1,209
Closed
319

Sector Composition

Rank Sector Weight
1 Technology 14.03%
2 Financials 8.59%
3 Healthcare 7.35%
4 Industrials 6.62%
5 Consumer Discretionary 5.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARCT icon
4101
Arcturus Therapeutics
ARCT
$160M
$1K ﹤0.01%
36
ASC icon
4102
Ardmore Shipping
ASC
$675M
$1K ﹤0.01%
113
ASHR icon
4103
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.53B
$1K ﹤0.01%
29
-171
-86% -$6.13K
ATAI icon
4104
AtaiBeckley Inc
ATAI
$2.65B
$1K ﹤0.01%
205
+100
+95% +$556
ATOS icon
4105
Atossa Therapeutics
ATOS
$23.7M
$1K ﹤0.01%
60
AUROW
4106
Aurora Innovation Warrant
AUROW
$328M
$1K ﹤0.01%
400
AXDX
4107
DELISTED
Accelerate Diagnostics
AXDX
$1K ﹤0.01%
87
+81
+1,350% +$2.31K
BAP icon
4108
Credicorp
BAP
$30.9B
$1K ﹤0.01%
+6
New +$906
BBUC
4109
Brookfield Business Corp Class A Subordinate Voting Shares
BBUC
$6.57B
$1K ﹤0.01%
+36
New +$1.13K
BCBP icon
4110
BCB Bancorp
BCBP
$182M
$1K ﹤0.01%
68
BKSY icon
4111
BlackSky Technology
BKSY
$890M
$1K ﹤0.01%
+88
New +$1.84K
BMEA icon
4112
Biomea Fusion
BMEA
$88.2M
$1K ﹤0.01%
+281
New +$1.82K
BTAI icon
4113
BioXcel Therapeutics
BTAI
$25.9M
$1K ﹤0.01%
3
+2
+200% +$580
CASI
4114
DELISTED
CASI Pharmaceuticals
CASI
$1K ﹤0.01%
150
CBNK icon
4115
Capital Bancorp
CBNK
$602M
$1K ﹤0.01%
29
CCNE icon
4116
CNB Financial Corp
CCNE
$1.04B
$1K ﹤0.01%
40
CDZI icon
4117
Cadiz
CDZI
$252M
$1K ﹤0.01%
616
-1,719
-74% -$4.33K
CKPT
4118
DELISTED
Checkpoint Therapeutics
CKPT
$1K ﹤0.01%
+75
New +$1.61K
CLDX icon
4119
Celldex Therapeutics
CLDX
$2.77B
$1K ﹤0.01%
44
-72
-62% -$2.3K
CLRB icon
4120
Cellectar Biosciences
CLRB
$19.3M
$1K ﹤0.01%
7
CMMB
4121
Chemomab Therapeutics
CMMB
$10.3M
$1K ﹤0.01%
+49
New +$966
COCP icon
4122
Cocrystal Pharma
COCP
$12.7M
$1K ﹤0.01%
192
+167
+668% +$1.11K
CRDF icon
4123
Cardiff Oncology
CRDF
$62.7M
$1K ﹤0.01%
409
CTEC icon
4124
Global X ClimateTech ETF
CTEC
$23.8M
$1K ﹤0.01%
10
CTRM icon
4125
Castor Maritime
CTRM
$18.2M
$1K ﹤0.01%
30
+10
+50% +$154

Similar funds

CAPTRUST Financial Advisors's Q1 2022 Portfolio in Review

As of Q1 2022, CAPTRUST Financial Advisors held 5,652 positions worth $15.4B, up 6% from $14.6B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

CAPTRUST Financial Advisors deployed $1.46B of net new capital in Q1 2022, opening 615 new positions and adding to 2,530 existing holdings. Its largest new stake was Enterprise Bancorp: 486,436 shares worth $19.5M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares MBS ETF, an estimated $63.8M trimmed.

  • CAPTRUST Financial Advisors's largest Q1 2022 buy was Enterprise Bancorp: 486,436 shares worth $19.5M.
  • CAPTRUST Financial Advisors added most to iShares 1-3 Year Treasury Bond ETF in Q1 2022, an estimated $244M increase.
  • CAPTRUST Financial Advisors's biggest Q1 2022 reduction was iShares MBS ETF, cutting an estimated $63.8M.
  • CAPTRUST Financial Advisors fully exited Berkshire Hathaway Class A in Q1 2022, selling an estimated $7.66M.
  • CAPTRUST Financial Advisors's ten largest holdings make up 23% of its $15.4B portfolio in Q1 2022.
  • CAPTRUST Financial Advisors opened 615 new positions and closed 319 in Q1 2022.
  • CAPTRUST Financial Advisors's portfolio value rose 6% quarter-over-quarter to $15.4B.

Based on CAPTRUST Financial Advisors's 13F filing for Q1 2022, filed 16 May 2022.